Shirly Amar

688 total citations
14 papers, 577 citations indexed

About

Shirly Amar is a scholar working on Molecular Biology, Genetics and Physiology. According to data from OpenAlex, Shirly Amar has authored 14 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Physiology. Recurrent topics in Shirly Amar's work include Wnt/β-catenin signaling in development and cancer (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Shirly Amar is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (3 papers), Amino Acid Enzymes and Metabolism (2 papers) and Epigenetics and DNA Methylation (2 papers). Shirly Amar collaborates with scholars based in Israel, Germany and United States. Shirly Amar's co-authors include Galila Agam, Carmit Nadri, Rogério Panizzutti, Herman Wolosker, Galila Agam, Robert H. Belmaker, Nitsan Kozlovsky, Yuly Bersudsky, Ofer Ovadia and Dan Mishmar and has published in prestigious journals such as Personality and Individual Differences, BMC Genomics and Schizophrenia Research.

In The Last Decade

Shirly Amar

13 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shirly Amar Israel 10 338 224 222 155 87 14 577
Carmit Nadri Israel 9 296 0.9× 222 1.0× 232 1.0× 139 0.9× 57 0.7× 13 491
Charles Vargas-Lopes Brazil 10 299 0.9× 277 1.2× 392 1.8× 260 1.7× 86 1.0× 10 750
Rosa Fradley United Kingdom 10 222 0.7× 319 1.4× 171 0.8× 107 0.7× 42 0.5× 13 490
Е. Б. Терешкина Russia 12 162 0.5× 182 0.8× 84 0.4× 146 0.9× 31 0.4× 55 462
Daniela Punzo Italy 13 205 0.6× 142 0.6× 185 0.8× 50 0.3× 72 0.8× 14 452
Mao Horio Japan 12 247 0.7× 259 1.2× 222 1.0× 198 1.3× 61 0.7× 14 516
О. К. Савушкина Russia 12 152 0.4× 171 0.8× 69 0.3× 161 1.0× 28 0.3× 59 478
T Nishikawa Japan 9 409 1.2× 341 1.5× 522 2.4× 79 0.5× 214 2.5× 22 822
David M. Otte Germany 11 192 0.6× 189 0.8× 68 0.3× 57 0.4× 21 0.2× 16 492
Joeri Van Liefferinge Belgium 14 228 0.7× 279 1.2× 124 0.6× 50 0.3× 13 0.1× 19 597

Countries citing papers authored by Shirly Amar

Since Specialization
Citations

This map shows the geographic impact of Shirly Amar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirly Amar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirly Amar more than expected).

Fields of papers citing papers by Shirly Amar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirly Amar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirly Amar. The network helps show where Shirly Amar may publish in the future.

Co-authorship network of co-authors of Shirly Amar

This figure shows the co-authorship network connecting the top 25 collaborators of Shirly Amar. A scholar is included among the top collaborators of Shirly Amar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirly Amar. Shirly Amar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Gao, Jun, Shirly Amar, Alastair D. Burt, et al.. (2025). Social discounting and anti-/pro-sociality: A meta-analysis and (short-form) replication. Personality and Individual Differences. 247. 113447–113447.
2.
Amar, Shirly, et al.. (2025). Efficacy and safety of anti-Xa direct oral anticoagulants vs. warfarin in patients homozygous for Factor V Leiden and prothrombin G20210A mutations. Journal of Thrombosis and Thrombolysis. 58(2). 188–198. 1 indexed citations
3.
Osher, Yamima, Shirly Amar, Abed N. Azab, et al.. (2012). Normobaric Hyperoxia Treatment of Schizophrenia. Journal of Clinical Psychopharmacology. 32(4). 525–530. 7 indexed citations
4.
Amar, Shirly, et al.. (2011). The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases. Current Pharmaceutical Design. 17(22). 2264–2277. 54 indexed citations
5.
Amar, Shirly, Ofer Ovadia, Wolfgang Maier, et al.. (2010). Copy number variation of the SELENBP1 gene in schizophrenia. Behavioral and Brain Functions. 6(1). 40–40. 13 indexed citations
6.
Mariotti, Veronica, Erika Melissari, Shirly Amar, et al.. (2010). Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays. Experimental Biology and Medicine. 235(3). 300–310. 17 indexed citations
7.
Toker, Lilah, Shirly Amar, Yuly Bersudsky, Jonathan Benjamin, & Ehud Klein. (2010). The biology of tryptophan depletion and mood disorders.. PubMed. 47(1). 46–55. 37 indexed citations
8.
Blech, Ilana, Ofer Ovadia, Shirly Amar, et al.. (2008). Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications. BMC Genomics. 9(1). 198–198. 31 indexed citations
9.
Amar, Shirly, Alon Shamir, Ofer Ovadia, et al.. (2007). Mitochondrial DNA HV lineage increases the susceptibility to schizophrenia among Israeli Arabs. Schizophrenia Research. 94(1-3). 354–358. 37 indexed citations
10.
Amar, Shirly, Galit Shaltiel, Alon Shamir, et al.. (2007). Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. The International Journal of Neuropsychopharmacology. 11(2). 197–205. 33 indexed citations
11.
Nadri, Carmit, et al.. (2006). A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophrenia Research. 90(1-3). 41–51. 272 indexed citations
12.
Amar, Shirly, Carmit Nadri, Rogério Panizzutti, et al.. (2006). Decreased D-serine levels in CSF of schizophrenia patients. European Neuropsychopharmacology. 16. S10–S10. 1 indexed citations
13.
Kozlovsky, Nitsan, Shirly Amar, Robert H. Belmaker, & Galila Agam. (2005). Psychotropic drugs affect Ser9-phosphorylated GSK-3β protein levels in rodent frontal cortex. The International Journal of Neuropsychopharmacology. 9(3). 337–337. 59 indexed citations
14.
Amar, Shirly, Byron C. Jones, Carmit Nadri, et al.. (2004). Genetic correlational analysis of glycogen synthase kinase‐3β and prepulse inhibition in inbred mice. Genes Brain & Behavior. 3(3). 178–180. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmit Nadri Breakdown of academic impact, for papers by Charles Vargas-Lopes Breakdown of academic impact, for papers by Rosa Fradley Breakdown of academic impact, for papers by Е. Б. Терешкина Breakdown of academic impact, for papers by Daniela Punzo Breakdown of academic impact, for papers by Mao Horio Breakdown of academic impact, for papers by О. К. Савушкина Breakdown of academic impact, for papers by T Nishikawa Breakdown of academic impact, for papers by David M. Otte Breakdown of academic impact, for papers by Joeri Van Liefferinge
Rankless by CCL
2026